These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 16036275)

  • 1. Nicotine addiction through a neurogenomic prism: ethics, public health, and smoking.
    Caron L; Karkazis K; Raffin TA; Swan G; Koenig BA
    Nicotine Tob Res; 2005 Apr; 7(2):181-97. PubMed ID: 16036275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Black and White adults' perspectives on the genetics of nicotine addiction susceptibility.
    Park ER; Kleimann S; Youatt EJ; Lockhart A; Campbell EG; Levy DE; Halbert CH; Schmieder E; Krishna R; Shields AE
    Addict Behav; 2011 Jul; 36(7):769-72. PubMed ID: 21406316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tobacco use and dependence.
    Sohn M; Hartley C; Froelicher ES; Benowitz NL
    Semin Oncol Nurs; 2003 Nov; 19(4):250-60. PubMed ID: 14702859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacogenetics in the treatment of tobacco addiction].
    Quaak M; van Schooten FJ; van Schayck CP
    Tijdschr Psychiatr; 2013; 55(11):891-8. PubMed ID: 24242150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tobacco addiction and pharmacogenetics of nicotine metabolism.
    Swan GE; Lessov-Schlaggar CN
    J Neurogenet; 2009; 23(3):262-71. PubMed ID: 19152209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics factors influencing smoking cessation success; the importance of nicotine metabolism.
    Perez-Paramo YX; Lazarus P
    Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):333-349. PubMed ID: 33322962
    [No Abstract]   [Full Text] [Related]  

  • 7. 2018 Langley Award for Basic Research on Nicotine and Tobacco: Bringing Precision Medicine to Smoking Cessation.
    Bierut LJ
    Nicotine Tob Res; 2020 Feb; 22(2):147-151. PubMed ID: 30855677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA's new plan to reduce the nicotine in cigarettes to sub-addictive levels could be a game-changer.
    Proctor RN
    Tob Control; 2016 Sep; 26(5):487-488. PubMed ID: 28831030
    [No Abstract]   [Full Text] [Related]  

  • 9. Smokers' Understandings of Addiction to Nicotine and Tobacco: A Systematic Review and Interpretive Synthesis of Quantitative and Qualitative Research.
    Pfeffer D; Wigginton B; Gartner C; Morphett K
    Nicotine Tob Res; 2018 Aug; 20(9):1038-1046. PubMed ID: 29059355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidating the role of genetic factors in smoking behavior and nicotine dependence.
    Lerman C; Berrettini W
    Am J Med Genet B Neuropsychiatr Genet; 2003 Apr; 118B(1):48-54. PubMed ID: 12627466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental influences on tobacco use: evidence from societal and community influences on tobacco use and dependence.
    Cummings KM; Fong GT; Borland R
    Annu Rev Clin Psychol; 2009; 5():433-58. PubMed ID: 19327036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics and smoking cessation improving outcomes in smokers at risk.
    Lerman CE; Schnoll RA; Munafò MR
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S398-405. PubMed ID: 18021915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician barriers to incorporating pharmacogenetic treatment strategies for nicotine dependence into clinical practice.
    Schnoll RA; Shields AE
    Clin Pharmacol Ther; 2011 Mar; 89(3):345-7. PubMed ID: 21326262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurogenetic determinants and mechanisms of addiction to nicotine and smoked tobacco.
    Sharp BM; Chen H
    Eur J Neurosci; 2019 Aug; 50(3):2164-2179. PubMed ID: 30256469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addiction Potential of Cigarettes With Reduced Nicotine Content in Populations With Psychiatric Disorders and Other Vulnerabilities to Tobacco Addiction.
    Higgins ST; Heil SH; Sigmon SC; Tidey JW; Gaalema DE; Hughes JR; Stitzer ML; Durand H; Bunn JY; Priest JS; Arger CA; Miller ME; Bergeria CL; Davis DR; Streck JM; Reed DD; Skelly JM; Tursi L
    JAMA Psychiatry; 2017 Oct; 74(10):1056-1064. PubMed ID: 28832876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chipping away at the genetics of smoking behavior.
    Amos CI; Spitz MR; Cinciripini P
    Nat Genet; 2010 May; 42(5):366-8. PubMed ID: 20428092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions to reduce harm from continued tobacco use.
    Lindson-Hawley N; Hartmann-Boyce J; Fanshawe TR; Begh R; Farley A; Lancaster T
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005231. PubMed ID: 27734465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroimaging, genetics and the treatment of nicotine addiction.
    Ray R; Loughead J; Wang Z; Detre J; Yang E; Gur R; Lerman C
    Behav Brain Res; 2008 Nov; 193(2):159-69. PubMed ID: 18599130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-pharmacological Considerations in Human Research of Nicotine and Tobacco Effects: A Review.
    Schlagintweit HE; Perry RN; Darredeau C; Barrett SP
    Nicotine Tob Res; 2020 Jul; 22(8):1260-1266. PubMed ID: 31058286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
    Benowitz NL
    Clin Pharmacol Ther; 2008 Apr; 83(4):531-41. PubMed ID: 18305452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.